| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |